The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.

On a recent podcast, one of the nation's top genetic genealogists and DNA analysts argued that a new method used to catch one ...

For decades, we've been told “Lower LDL is Better.” But what if, in our myopic obsession with LDL and ApoB, we’ve missed a ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A non-invasive topical treatment for diabetic macular edema ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

Selection is the main goal of plant breeders and geneticists to genetically improve target traits in cereal crops. Resistance ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A non-invasive ...

Genetic research in Parkinson disease (PD) and related disorders has advanced significantly in recent years, primarily through large-scale genome-wide ...

A study of more than 4,500 US infants exposed to hepatitis C virus (HCV) in utero or at birth from 2014 to 2021 finds that ...

Becoming a biohacker isn't as easy as it sounds. As exciting as it is to think about taking charge of your own health, ...

There’s more history in your blood types than you think, and it didn’t begin with humans. Here’s what we know about them, ...